A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2012-02-17
Summary
To evaluate the safety and efficacy of BLINK™ tears compared with NO topical artificial tear use in improving subject's visual performance and reduce ocular symptoms of discomfort in subjects who have undergone cataract surgery implanted with a Tecnis™ diffractive multifocal intraocular lens (IOL).
Conditions
- Dry Eye
Interventions
- DRUG
-
No topical artificial tear
40 patients randomized to not using a topical artificial tear.
- DRUG
-
Blink® Tears Lubricant Eye Drops
Blink® Tears Lubricant Eye Drops
Sponsors & Collaborators
-
Innovative Medical
lead INDUSTRY
Principal Investigators
-
Marc Bloomenstein, M.D. · Schwartz Laser Eye Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Study of FID 119515A
NCT01833117 ·Status: COMPLETED ·Phase: NA
-
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
NCT06162442 ·Status: RECRUITING
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
NCT02380248 ·Status: COMPLETED ·Phase: NA
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Managing Dry Eye in Patients Using Glaucoma Drops
NCT06158984 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease
NCT04683796 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease
NCT04608084 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
NCT01682460 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients
NCT04063644 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
NCT06017362 ·Status: RECRUITING ·Phase: PHASE4
-
Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye
NCT06686368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
NCT01163643 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TL-925 as a Treatment for Dry Eye Disease
NCT05745064 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1